Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition

Chest

Volumn 117, Issue 5 SUPPL. 2, 2000, Pages 339S-345S

  Viegi, Giovanni ^a   Pedreschi, Marzia ^b   Pistelli, Francesco ^b   Di Pede, Francesco ^b   Baldacci, Sandra ^b   Carrozzi, Laura ^b   Giuntini, Carlo ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b NONE

Author keywords

Airways obstruction definition; COPD; Epidemiological survey; FEV1; FVC; General population; Prevalence

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; STANDARDIZATION; STATISTICAL MODEL; UNITED STATES; VITAL CAPACITY;

EID: 0034124046     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-S120
2. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1398-1420
3. World Health Organization. Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. Bethesda, MD: National Institutes of Health, 1993; 95
4. Desideri M, Viegi G, Carrozzi L, et al. Mortality rates for respiratory disorders in Italy (1979-1990). Monaldi Arch Chest Dis 1997; 52:212-216
5. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
6. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986; 133:1205-1209
7. Lundbäck B, Nystrom L, Rosenhall L, et al. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991; 4:257-266
8. Viegi G, Paoletti P, Carrozzi L, et al. Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of air pollution. Environ Health Perspect 1991; 94:95-99
9. Manfreda J, Mao Y, Litven W. Morbidity and mortality from chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140:S19-S26
10. Higgins MW, Keller JB. Trends in COPD morbidity and mortality in Tecumseh, Michigan. Am Rev Respir Dis 1989; 140:S42-S48
11. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14-20
12. 1: the Lung Health Study. JAMA 1994; 272:1497-1505
13. van Schayck CP, van Grunsven PM, Dekhuijzen PNR. Do patients with COPD benefit from treatment with inhaled corticosteroids? Eur Respir J 1996; 9:1969-1972
14. Baldacci S, Carrozzi L, Viegi G, et al. Assessment of respiratory effect of air pollution: study design on general population samples. J Environ Pathol Toxicol Oncol 1997; 16:77-83
15. Carrozzi L, Giuliano G, Viegi G, et al. The Po River Delta epidemiological study of obstructive lung disease: sampling methods, environmental and population characteristics. Eur J Epidemiol 1990; 6:191-200
16. Viegi G, Paoletti P, Prediletto R, et al. Prevalence of respiratory symptoms in an unpolluted area of northern Italy. Eur Respir J 1988; 1:311-318
17. Paoletti P, Pistelli G, Fazzi P, et al. Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir 1986; 22:451-459
18. Viegi G, Carrozzi L, Di Pede F, et al. Risk factors for chronic obstructive pulmonary disease in a North Italian rural area. Eur J Epidemiol 1994; 10:1-7
19. Paoletti P, Carrozzi L, Viegi G, et al. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking and level of pulmonary function. Am J Respir Crit Care Med 1995; 151:1770-1777
20. Pistelli G, Carmignani G, Paoletti P, et al. Comparison of algorithms for determining the end-point of the forced vital capacity maneuver. Chest 1987; 91:100-105
21. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
22. Knapp RG, Clinton Miller M III. Clinical epidemiology and biostatistics. Malvern, PA: Harwal Publishing Company, 1992; 31-51
23. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
24. US Public Health Service. The health consequences of smoking: chronic obstructive lung disease; a report of Surgeon General. Rockville, MD: Government Printing Office, 1984; DHHS Publ (PHS) 84-50205
25. Lebowitz MD. The trends in airway obstructive disease morbidity in the Tucson Epidemiological Study. Am Rev Respir Dis 1989; 140(3 Pt 2):S35-S41
26. De Marco R, Verlato G, Zanolin E, et al. Nonresponse bias in EC Respiratory Health Survey in Italy. Eur Respir J 1994; 7:2139-2145
27. Canadian Thoracic Society. Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 1992; 147:420-428
28. Thoracic Society of Australia and New Zealand. Guidelines for the management of chronic obstructive pulmonary disease. Mod Med Aust 1995; 38:132-146
29. British Thoracic Society guidelines for the management of chronic obstructive pulmonary disease: the COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52:S1-28